trifluoroacetamide has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, U; Beetar-King, T; Bruce, CB; Buczkowski, H; Burton, C; Cane, PA; Davies, K; Green, N; Hannah, MJ; Hettiarachchi, N; Jones, M; Killip, MJ; Roberts, ADG; Spencer, P; Strachan, R; Welch, SR; Woodford, N | 1 |
1 other study(ies) available for trifluoroacetamide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Virucidal efficacy of guanidine-free inactivants and rapid test buffers against SARS-CoV-2.
Topics: Acetamides; Antiviral Agents; Buffers; COVID-19; COVID-19 Serological Testing; Fluoroacetates; Guanidine; Humans; SARS-CoV-2; Virus Inactivation | 2021 |